Team Hewins LLC Makes New $374,000 Investment in Colgate-Palmolive (NYSE:CL)

Team Hewins LLC acquired a new position in shares of Colgate-Palmolive (NYSE:CL) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 4,694 shares of the company’s stock, valued at approximately $374,000.

Other hedge funds also recently made changes to their positions in the company. Union Savings Bank lifted its holdings in shares of Colgate-Palmolive by 76.6% during the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after acquiring an additional 134 shares in the last quarter. Avion Wealth raised its position in shares of Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after purchasing an additional 175 shares in the last quarter. Atlantic Edge Private Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at approximately $32,000. McGlone Suttner Wealth Management Inc. acquired a new stake in Colgate-Palmolive in the fourth quarter valued at $34,000. Finally, Kayne Anderson Rudnick Investment Management LLC boosted its stake in Colgate-Palmolive by 142.0% during the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after acquiring an additional 291 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 0.5 %

CL traded down $0.43 on Friday, reaching $93.30. 2,554,810 shares of the company traded hands, compared to its average volume of 4,674,141. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $95.59. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70. The company has a market cap of $76.55 billion, a price-to-earnings ratio of 29.53, a PEG ratio of 3.45 and a beta of 0.40. The stock’s 50 day moving average price is $90.38 and its 200-day moving average price is $84.37.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The business had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period last year, the company earned $0.73 earnings per share. Colgate-Palmolive’s quarterly revenue was up 6.2% compared to the same quarter last year. On average, sell-side analysts expect that Colgate-Palmolive will post 3.53 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Monday, April 22nd were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.14%. The ex-dividend date was Friday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Insider Transactions at Colgate-Palmolive

In related news, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the transaction, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, insider Sally Massey sold 12,226 shares of Colgate-Palmolive stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares in the company, valued at approximately $297,328.07. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CL has been the topic of several research analyst reports. Argus increased their price target on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research report on Wednesday, May 15th. Morgan Stanley lifted their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. Bank of America increased their price target on Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, April 29th. Barclays boosted their price objective on Colgate-Palmolive from $84.00 to $85.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 30th. Finally, UBS Group raised their target price on Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, January 29th. Three research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $92.35.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.